Product Information
LACOSAMIDE 50 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1186 per EA under NDC 16714054801. Its NADAC has been published 200 times since Dec 7, 2022.
FDA first approved this application on Mar 17, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714054801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208308FDA Approved
3/17/2022
TE Code
AB
On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 50 MG TABLET has been published 200 times since Dec 7, 2022, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1186 per EA |
|---|---|
| All-time high | $0.2135 (Mar 15, 2023) |
| All-time low | $0.1045 (Nov 20, 2024) |
| 52-week high | $0.1336 |
| 52-week low | $0.1046 |
| Median price | $0.1487 |
| Average price | $0.1544 |
| Largest weekly change | +38.3% (Aug 21, 2024) |
| Weeks tracked | 200 |
| Tracking since | Dec 7, 2022 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lacosamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LACOSAMIDE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 50 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1186 per EA (NDC 16714054801), effective Sep 30, 2026.
How has the price of LACOSAMIDE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 50 MG TABLET has declined 31.7%. It has been tracked across 200 weekly CMS publications since Dec 7, 2022.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 50 MG TABLET?
Since Dec 7, 2022, the NADAC for LACOSAMIDE 50 MG TABLET has ranged from a low of $0.1045 (Nov 20, 2024) to a high of $0.2135 (Mar 15, 2023), with a median of $0.1487 per EA.
Are there cheaper alternatives to LACOSAMIDE 50 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LACOSAMIDE 50 MG TABLET, is $0.1061 per EA — about 11% below LACOSAMIDE 50 MG TABLET.
Who manufactures LACOSAMIDE 50 MG TABLET?
LACOSAMIDE 50 MG TABLET (NDC 16714054801) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.